Cost The annual cost of treating psoriasis in the United States is estimated as high as $32.5billion, including $12.2billion in direct costs. Pharmacy costs are the main source of direct expense, with biologic therapy the most prevalent. These costs increase significantly when co-morbid conditions such as heart disease, hypertension, diabetes, lung disease, and psychiatric disorders are factored in. Expenses linked to co-morbidities are estimated at an additional $23,000 per person per year.
Cost The annual cost of treating psoriasis in the United States is estimated as high as $32.5billion, including $12.2billion in direct costs. Pharmacy costs are the main source of direct expense, with biologic therapy the most prevalent. These !costs increase significantly when co-morbid conditions such as heart disease, hypertension, diabetes, lung disease, and psychiatric disorders are factored in. Expenses linked to co-morbidities ar,e estimated at an ?additional $23,000 per person per year.